Hodinový prehľad - Zdravotnícke a vedecké zaujímavosti

Vygenerované: 28.10.2026 23:37:39

Geron discontinues late stage skúška of krv rakovina liek shares plunge

Zdroj: Medscape

URL: https://www.medscape.com/s/viewarticle/geron-discontinues-late-stage-trial-blood-cancer-drug-shares-2026a10014wz?src=rss

Súhrn:

Súhrn: Oct 28 (Reuters) - Geron said on Wednesday it would halt a late-stage trial of its blood cancer treatment, marking a setback for the company's only commercial product, sending its shares plunging 20% in early trading The drug, branded as Rytelo, was being evaluated as a treatment for myelofibrosis, a rare type of blood cancer in which scar tissue gradually builds up in the bone marrow Geron said it made the decision following an independent data monitoring committee's recommendation that the trial, named IMpactMF, was unlikely to achieve its main goal of overall survival, compared with the best available therapy.

Dovetok:

Doplnenie: Rytelo received US approval in 2024 for treating transfusion-dependent anemia in patients with lower-risk myelodysplastic syndromes (LR-MDS), a group of blood cancers.

Achilles injections show no meaningful benefit over sham liečba

Zdroj: Medical Xpress

URL: https://medicalxpress.com/news/2026-10-achilles-meaningful-benefit-sham-treatment.html

Súhrn:

Súhrn: Achilles injections show no meaningful benefit over sham treatment Sadie Harley Scientific Editor Andrew Zinin Chief Editor Commonly used injections for Achilles tendinopathy—pain, stiffness and swelling in the Achilles tendon—offer no meaningful clinical advantage over placebo (sham) treatment, finds a clinical trial published by The BMJ While exercise-based therapy is recommended, up to 44% of patients do not recover and many seek alternative options, including injection therapy To address this, researchers enrolled 192 adults (mean age 49; 55% male) with midportion Achilles tendinopathy from a radiology clinic in Melbourne, Australia, between December 2019 and July 2022.

Dovetok:

Doplnenie: While exercise-based therapy is recommended, up to 44% of patients do not recover and many seek alternative options, including injection therapy.